Comparison of Two Summative Assessment Methods in Advanced Life Support Courses

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Completed
CT.gov ID
NCT03412032
Collaborator
(none)
428
1
2
24.9
17.2

Study Details

Study Description

Brief Summary

Several approaches for summative assessment during Advanced Life Support courses are used. The most commonly used method during European Resuscitation (ERC) Council Life Support Courses is that 1 instructor is miming a whole team, and the candidate has to lead this "team" through a scenario; another variant of the summative assessment (mainly used by American Heart Association (AHA) Courses) is with a group of students, where one student is the team leader to be assessed and the others are his team not being assessed. The second approach might be more realistic; however there is no evidence around with regard to effectiveness (pass/fail rate, ability to test non-technical skills (NTS)) or participant/assessor satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Other: assessment
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
428 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Comparison of Two Summative Assessment Methods in Advanced Life Support Courses - a Randomized Controlled Trial
Actual Study Start Date :
Dec 2, 2017
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: ERC

Assessment as used by the European Resuscitation Council

Other: assessment
different assessments in both arms

Other: AHA

Assessment as used by the American Heart Association

Other: assessment
different assessments in both arms

Outcome Measures

Primary Outcome Measures

  1. Team leadership [1 minute after the assessment is completed]

    Subjective rating of team leadership

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All medical students at the University of Bern, study year 2017/2018, 5th and 6th study year
Exclusion Criteria:
  • Refusal to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Bern Bern Switzerland

Sponsors and Collaborators

  • University Hospital Inselspital, Berne

Investigators

  • Study Chair: Robert Greif, University of Bern, Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT03412032
Other Study ID Numbers:
  • ILS_2017/2018
First Posted:
Jan 26, 2018
Last Update Posted:
Feb 5, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 5, 2020